FIASP (insulin aspart) Patient Assistance Program
Don’t let the high cost of brand ultra-rapid-acting insulin disrupt your diabetes management. We help eligible patients access Fiasp (insulin aspart) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Fiasp (insulin aspart, faster-acting) is FDA-approved to improve glycemic control in adults and pediatric patients (≥1 year) with diabetes mellitus. It is an ultra-rapid-acting mealtime insulin analog — the same insulin aspart as NovoLog but reformulated with niacinamide and L-arginine to accelerate absorption (onset within 4 minutes; effective 'mealtime' option that can be dosed at the start of a meal or up to 20 minutes after).
- Without assistance, brand Fiasp costs commonly run approximately $250–$340 per 10 mL vial or per 5-pen pack of FlexTouch prefilled pens.
- Through AffordMyPrescriptions, qualifying patients can access Fiasp for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Biosimilars/follow-ons to insulin aspart are available (NovoLog and its biosimilars, and authorized generic insulin aspart). Other ultra-rapid mealtime insulins include Lyumjev (faster insulin lispro). Medicare Part D's $35/month insulin cap applies to Fiasp for beneficiaries.
What Is Fiasp Prescription Assistance Program?
The Fiasp Prescription Assistance Program is a manufacturer-sponsored initiative that provides Fiasp at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for diabetes patients requiring ultra-rapid-acting insulin who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, endocrinology/primary care coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and renewal.
Pharmacy Price Comparison
- Without assistance, Fiasp costs roughly $250–$340 per vial or pen pack. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$330 | Save ~$260/mo |
| CVS Pharmacy | ~$340 | Save ~$270/mo |
| Walmart | ~$280 | Save ~$210/mo |
| Costco | ~$260 | Save ~$190/mo |
Medicare Part D cap | $35/mo | Federal cap |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Fiasp Prescription Program?
The Patient Assistance Program is free to apply for and provides Fiasp at no medication cost if approved. Our $69.95/month service covers full advocacy. With Medicare Part D’s $35/month insulin cap and biosimilar/authorized generic mealtime insulins available, we’ll help you and your provider determine the most affordable path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Fiasp:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $250–$340 per month even with the best discoun
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Fiasp assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Fiasp Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Fiasp:
Fiasp (faster-acting insulin aspart) is an ultra-rapid-acting mealtime insulin analog. It contains the same insulin aspart molecule as NovoLog but is reformulated with niacinamide (vitamin B3, increases absorption rate) and L-arginine (stabilizer) — resulting in faster onset that better matches post-meal glucose absorption.
How Fiasp Works:
Dietary carbohydrates rapidly raise blood glucose after eating, typically peaking within 30–60 minutes, which means traditional rapid-acting insulins with a 15-minute onset often lag behind this spike. Fiasp is an ultra-rapid insulin designed to better match this physiologic glucose absorption by utilizing a niacinamide additive. This additive increases the rate of insulin absorption from subcutaneous tissue, accelerating the onset of action to approximately 4 minutes. This rapid onset allows for dosing at the very start of a meal or shortly after, providing optimal post-meal glucose control especially for type 1 diabetes patients.
Form and use:
Fiasp is administered via a subcutaneous injection either at the start of a meal or up to 20 minutes after the meal has begun. Individual dosages are tailored specifically to the patient based on their carbohydrate intake, current blood glucose levels, and personal insulin sensitivity. The medication is commercially available in both 10 mL vials and 3 mL FlexTouch prefilled pens, and it is also approved for use in insulin pumps. Patients must remember to regularly rotate their injection sites to ensure proper skin health and consistent absorption.
Generic availability:
An authorized generic insulin aspart is available under its generic name at a substantially lower cost than the brand-name Fiasp or NovoLog. While NovoLog and its biosimilars provide traditional rapid-acting insulin aspart, Lyumjev serves as another ultra-rapid mealtime option utilizing faster-acting insulin lispro. To help with affordability, the Medicare Part D program applies a $35 per month insulin cap to most covered insulins. Choosing between these rapid and ultra-rapid options often depends on a patient’s specific coverage and required onset timing.
Warnings:
Hypoglycemia is the most common adverse effect associated with Fiasp, requiring patients to monitor their blood glucose and always carry a rapid-acting glucose source. The insulin can cause hypokalemia by shifting potassium into cells, and it can lead to fluid retention or heart failure if used in combination with thiazolidinediones. Rare but severe allergic reactions can occur, and patient insulin requirements can fluctuate significantly with changes in illness, physical activity, meals, or other concurrent diabetes medications.
FAQ (Frequently Asked Questions)
How Much Does Fiasp Cost Without Insurance?
Brand Fiasp costs approximately $250–$340 per vial or pen pack. Medicare Part D beneficiaries pay $35/month maximum for covered insulin. Authorized generic insulin aspart is cheaper than brand. Through AffordMyPrescriptions, qualifying patients receive Fiasp at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Fiasp Different From NovoLog?
Same active ingredient (insulin aspart), different formulation. Fiasp contains niacinamide and L-arginine that accelerate absorption — onset within 4 minutes vs. ~15 minutes for NovoLog. Fiasp can be dosed at the start of a meal (or up to 20 minutes after meal start), while NovoLog should be dosed 15 minutes before meals. The faster onset of Fiasp may improve post-meal glucose control. Many patients use either with similar overall A1c results.
How Does Fiasp Compare To Lyumjev?
Both are ultra-rapid mealtime insulin analogs. Fiasp is faster-acting insulin aspart with niacinamide/L-arginine additives. Lyumjev is faster-acting insulin lispro with treprostinil and citrate additives. Both have similar accelerated onset (~4 minutes) and can be dosed at the start of meals. Choice depends on insurance coverage, personal preference, and provider familiarity.
What About The Medicare $35 Insulin Cap?
Effective January 1, 2023, Medicare Part D capped patient out-of-pocket cost at $35/month per covered insulin product. This applies to all insulin formulations covered by Part D — making Fiasp and other insulins much more affordable for Medicare beneficiaries. Some Medicare Advantage and commercial plans also offer $35/month insulin caps; ask your plan.ts costing $2–3 million but potentially eliminating SCD complications. Available at specialized centers.
When Should I Inject Fiasp?
Inject Fiasp at the start of a meal or up to 20 minutes after the start of the meal. This is more flexible than traditional rapid-acting insulins (which should be dosed 15 minutes before meals). The flexibility is helpful when meal size, timing, or carbohydrate content is uncertain — though earlier injection (start of meal) typically provides better glucose control.
Can I Use Fiasp In An Insulin Pump?
Yes. Fiasp is FDA-approved for use in external insulin pumps. Some pump users prefer Fiasp for the more rapid onset to address post-meal glucose excursions. As with all pump insulins, the infusion set should be changed regularly to prevent pump malfunction.
What If My Application Is Denied?
If denied, we explore alternatives — switching to authorized generic insulin aspart, NovoLog or its biosimilars, Lyumjev (faster insulin lispro), the manufacturer’s commercial copay program, Medicare $35/month cap if applicable, or independent foundations such as the American Diabetes Association, JDRF, or PAN Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Fiasp, our team may be able to help you access assistance programs — or guide you to a more affordable insulin option including authorized generic insulin aspart or the Medicare $35/month cap. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.